RE: The "O" word...the options are coming!C'mon fellas, let's get these options doled out and get on with the program.
Typically the firm grants options in late January or early February.
"Clearly" ( throat clear ), the US was not impressed by the massive IR program of last week ; - (
I say we reach out to Asia and the EU and figure out exactly what they are doing to be so beneficial in the CV19 battle. The Euphas2 registry is simply an expansion of the rather stunning ( BUT not all related to EDT ) results of the original Euphas phase II trial in Italy.
I figure the FDA would NOT have allowed / added a third CV19 site to our exisiting CV19 trial if the results from Stony Brook and George Harrison were "futile"..."My sweet lord"...it's time to amp up the fight against CV19...especially when we have the products that back in March appeares to be "so helpful" ??